← All stocks

Karyopharm Therapeutics Inc.

KPTI Net selling
CIK 0001503802 #4777 in the set updated 17 Sep 2026
Bought (120 mo)
$390.27K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$59.40M
$85.02K on a plan · $22.93M straight out of an exercise
Sold at will
$36.39M
214 of 385 sales
Net
−$59.01M
−$36.00M against sales at will

By person

25 insiders · 391 transactions
0.7×

Richard Paulson holds only 0.7 times base salary in stock. $544.89K of shares against $770.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Richard Paulson last reported holding, valued at $2.02, the price Common Stock was last bought or sold at on the open market here, on 1 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Chione Ltd entity
10% owner
$26.06M (23)
−$26.06M
6,000,000
$12.12M
−29.8%
Kauffman Michael
Director
$9.73M (74) scheduled
−$9.73M
2,532,040
$5.11M
+4.9%
Shacham Sharon
Chief Scientific Officer
$9.73M (74) scheduled
−$9.73M
2,386,714
$4.82M
+8.1%
Primiano Christopher Brett
EVP, CBO, GC & Secretary
$5.23M (31) scheduled
−$5.23M
4,523
$9.14K
−64.2%
PAKIANATHAN DEEPIKA
Director
$5.10M (18)
−$5.10M
15,508
$31.33K
−99.3%
Mirza Mansoor Raza
Director
$1.33M (22) scheduled
−$1.33M
0
$0.00
Paulson Richard A.
President and CEO
$875.85K (46)
−$875.85K
269,747
$544.89K
Frenkel Ran
EVP, Chief Dev. Officer
$324.29K (9)
−$324.29K
168,290
$339.95K
+252.4%
Mason Michael
EVP, CFO & Treasurer
$234.16K (16)
−$234.16K
391,054
$789.93K
+1,499%
Cheng Sohanya Roshan
EVP & Chief Commercial Officer
$162.02K (12)
−$162.02K
107,940
$218.04K
Poulton Stuart
EVP, Chief Development Officer
$146.75K (17)
−$146.75K
94,632
$191.16K
Rangwala Reshma
EVP & Chief Medical Officer
$144.18K (11)
−$144.18K
56,829
$114.79K
DEMAREE JOHN
Chief Commercial Officer
$109.01K (1)
+$109.01K
23,995
$48.47K
+3,614%
Mano Michael
EVP, CLO&Secretary
$107.80K (9)
−$107.80K
94,398
$190.68K
Shah Jatin
EVP, Chief Medical Officer
$199.99K (1)
$111.48K (6)
+$88.51K
129,450
$261.49K
+72.6%
BOHLIN GAREN G
Director
$81.27K (2)
+$81.27K
18,517
$37.40K
Renz Justin A
EVP, CFO & Treasurer
$35.54K (1)
−$35.54K
19,173
$38.73K
+125.2%
Lewis Tanya
EVP, Chief Reg. Affairs
$35.27K (2)
−$35.27K
45,401
$91.71K
+135.9%
Mitchener Stephen
SVP, Chief Business Officer
$27.50K (3)
−$27.50K
128,313
$259.19K
+1,747%
Abate Kristin
Chief Accounting Officer
$14.78K (10)
−$14.78K
23,782
$48.04K
+99.1%
Macomber Lori
EVP, CFO & Treasurer
$10.24K (1)
−$10.24K
85,105
$171.91K
Greene Barry E
Director
16,415
$33.16K
Oliger Christy J.
Director
15,508
$31.33K
Su Zhen
Director
15,508
$31.33K
Schor Chen
Director
15,508
$31.33K

No percentages here. This company's share count has moved by a factor of 1,973.5 over the window, from 8,639,904 to 17,050,876,000 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Paulson Richard A.
7 Aug 2023
President and CEO
Sold on a plan
3,722
$1.72
$6.40K
Poulton Stuart
28 Jul 2023
EVP, Chief Development Officer
Sold on a plan
2,845
$1.70
$4.84K
Paulson Richard A.
5 Jul 2023
President and CEO
Sold on a plan
3,538
$1.72
$6.09K
Cheng Sohanya Roshan
8 Jun 2023
EVP & Chief Commercial Officer
Sold on a plan
1,839
$2.35
$4.32K
Paulson Richard A.
5 Jun 2023
President and CEO
Sold on a plan
3,536
$2.24
$7.92K
Mason Michael
2 Jun 2023
EVP, CFO & Treasurer
Sold on a plan
631
$2.22
$1.40K
Paulson Richard A.
4 May 2023
President and CEO
Sold on a plan
3,805
$3.35
$12.75K
Rangwala Reshma
20 Apr 2023
EVP & Chief Medical Officer
Sold on a plan
6,655
$4.05
$26.95K
Rangwala Reshma
20 Apr 2023
EVP & Chief Medical Officer
Sold on a plan
115
$4.03
$463.07
Paulson Richard A.
4 Apr 2023
President and CEO
Sold on a plan
3,497
$3.97
$13.88K
Showing 250 of 391 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 457
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 10
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 161
Sales at will 214
Transactions with no price 0
Shares from compensation/vesting 6,581,376
Sales filed before the plan box existed 119
History held since 8 Nov 2016